Anzeige
Mehr »
Mittwoch, 13.05.2026 - Börsentäglich über 12.000 News
Bahnbrechende KI-Lösung "Ohne Nadelstiche" als Ersatz für herkömmliche Bluttests "unlocked"?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C8W1 | ISIN: SE0017131824 | Ticker-Symbol: I81
Frankfurt
13.05.26 | 08:05
2,160 Euro
+3,85 % +0,080
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CAREIUM AB Chart 1 Jahr
5-Tage-Chart
CAREIUM AB 5-Tage-Chart
RealtimeGeldBriefZeit
2,1502,29021:10
GlobeNewswire (Europe)
274 Leser
Artikel bewerten:
(1)

Careium AB: Careium reports first quarter results 2026

Summary first quarter 2026

  • Net sales increased by 5.9 percent to SEK 219.6 million (207.4)
    • Net sales increased by 10.9 percent adjusted for currency effects
    • Growth in all markets, adjusted for currency effects
  • Gross margin amounted to 43.2 percent (44.5)
  • Operating profit (EBIT) amounted to SEK 12.5 million (16.6), and the operating margin to 5.7 percent (8.0)
    • Impacted by initiatives in product development and business integration as well as the onboarding of a large customer in Norway
  • Profit for the period increased to SEK 8.4 million (7.5) corresponding to earnings per share of SEK 0.31 (0.29)
  • Free cash flow amounted to SEK -14.0 million (-4.4) following build-up of working capital to normalized levels in the quarter
  • Cash increased to SEK 37.9 million (37.4) at the end of the quarter

CEO statement first quarter
Careium delivered a solid performance during the period, reporting healthy growth with net sales increasing by 10.9 percent adjusted for currency effects. Despite previously communicated short-term pressure on operating margins, we delivered a higher profit for the period. Our progress demonstrates the underlying strength of our business and our ability to execute while investing for the future.

Product sales increased by 18.1 percent to SEK 55.6 million, while service sales grew by 2.3 percent to SEK 163.9 million. Gross margin amounted to 43.2 percent, reflecting a continued stable profitability in our core operations.

While margin pressure impacted the quarter, we increased profit for the period to SEK 8.4 million compared with SEK 7.5 million last year. As previously communicated, our structural improvement initiatives affected operating margins in the quarter and are expected to do so also in the second quarter. Additionally, the onboarding of a large customer in Norway led to upfront costs that temporarily impacted margins. These investments are part of our long-term profitability and growth strategy.

The first quarter of 2025 benefited from accruals in the UK, as previously communicated. Adjusting for these accruals, gross margin, EBIT and EBITDA all improved in the first quarter of 2026 compared to the same period last year.

Careium holds a strong position in several key European markets, with bridgeheads in large and growing populations. Demographic trends, particularly an aging population, are driving demand, while the care sector continues to be transformed through technology. With a renewed and more efficient operating model, we are well positioned to capture this growth.

A large portion of our revenues is recurring, supported by long-term contracts and loyal customers, providing stability and a solid foundation. Our strong market position enables opportunities for both organic and selective non-organic growth in a fragmented market. We will approach consolidation with discipline, prioritising complementary businesses with clear and measurable synergies.

This is my last quarterly report as Interim CEO. I am pleased to confirm that Careium is making solid progress in integrating historic acquisitions, aligning our businesses across Europe and strengthening our customer offering. Our ambition is clear: to build a unified, modern European health tech company supported by a scalable care platform. We firmly believe that our initiatives in product development and business integration will create significant value over time.

On June 1, Tove Christiansson will join Careium as permanent CEO. With her extensive experience in the industry, she will continue to lead the transformation of Careium into a unified and modern European health tech company. I would like to warmly welcome Tove and express my sincere thanks to our Board of Directors and the entire organisation. Careium has a strong vision, a dedicated team and a meaningful role to play in the future of European care.

Peter Heuman

Interim CEO

Webcast

A live broadcast report presentation will be held Thursday April 23 at 08.30 am with CEO Peter Heuman and CFO David Granath.

The webcast is accessed on: https://youtube.com/live/BrEzIr0aH10

The presentation material will be available on: https://www.careium.com/en-gb/investors/financial-information/presentations/

For more information, please contact:
David Granath, CFO, +46 (0) 73 363 89 01
E-mail: ir@careium.com

About Us
Careium is a leading provider in Europe of technology-enabled care solutions, enhancing the safety, independence, and quality of life for seniors while improving operational efficiency for care providers. Careium is one of the few players that delivers end-to-end digital assisted living systems, including security alarms, smart sensors, accessories and secure communication platforms with alarm response.

By combining innovation with regulatory compliance, Careium empowers care providers to deliver smarter, safer, and more cost-effective support, freeing resources for higher-value care. Demand for home-based care solutions grows, and our recurring revenue model and technology gives us a strong position in the care tech market. The company is listed at Nasdaq First North Stockholm with FNCA Sweden AB as the Certified Adviser.

This information is information that Careium is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-04-23 08:00 CEST.

© 2026 GlobeNewswire (Europe)
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.